These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 10954663

  • 1. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
    Silverberg NB, Sidbury R, Mancini AJ.
    J Am Acad Dermatol; 2000 Sep; 43(3):503-7. PubMed ID: 10954663
    [Abstract] [Full Text] [Related]

  • 2. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection.
    Cathcart S, Coloe J, Morrell DS.
    Clin Pediatr (Phila); 2009 Mar; 48(2):161-5. PubMed ID: 18936288
    [Abstract] [Full Text] [Related]

  • 3. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
    Coloe J, Morrell DS.
    Pediatr Dermatol; 2009 Mar; 26(4):405-8. PubMed ID: 19689514
    [Abstract] [Full Text] [Related]

  • 4. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
    Moye V, Cathcart S, Burkhart CN, Morrell DS.
    Dermatol Ther; 2013 Mar; 26(6):445-51. PubMed ID: 24552407
    [Abstract] [Full Text] [Related]

  • 5. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
    Moye VA, Cathcart S, Morrell DS.
    Pediatr Dermatol; 2014 Mar; 31(4):450-4. PubMed ID: 24383663
    [Abstract] [Full Text] [Related]

  • 6. Cantharidin: a comprehensive review of the clinical literature.
    Torbeck R, Pan M, DeMoll E, Levitt J.
    Dermatol Online J; 2014 Jun 15; 20(6):. PubMed ID: 24945640
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
    Vakharia PP, Chopra R, Silverberg NB, Silverberg JI.
    Am J Clin Dermatol; 2018 Dec 15; 19(6):791-803. PubMed ID: 30097988
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF, McFalda W, Brabec B, Siegfried E, Kwong P, McBride M, Rieger J, Willson C, Davidson M, Burnett P.
    JAMA Dermatol; 2020 Dec 01; 156(12):1315-1323. PubMed ID: 32965495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Guzman AK, Schairer DO, Garelik JL, Cohen SR.
    Int J Dermatol; 2018 Aug 01; 57(8):1001-1006. PubMed ID: 29904968
    [Abstract] [Full Text] [Related]

  • 12. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
    Ross GL, Orchard DC.
    Australas J Dermatol; 2004 May 01; 45(2):100-2. PubMed ID: 15068455
    [Abstract] [Full Text] [Related]

  • 13. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
    Niazi S, Brabec B, Anschutz L, Willson C, Davidson M, Burnett P.
    J Drugs Dermatol; 2021 Jan 01; 20(1):70-75. PubMed ID: 33400412
    [Abstract] [Full Text] [Related]

  • 14. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF, Siegfried E, Kwong P, McBride M, Rieger J, Glover D, Willson C, Davidson M, Burnett P, Olivadoti M.
    Am J Clin Dermatol; 2021 Mar 01; 22(2):257-265. PubMed ID: 33599960
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. One-year experience with candida antigen immunotherapy for warts and molluscum.
    Maronn M, Salm C, Lyon V, Galbraith S.
    Pediatr Dermatol; 2008 Mar 01; 25(2):189-92. PubMed ID: 18429776
    [Abstract] [Full Text] [Related]

  • 19. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children.
    Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P, Thibeault H, McCuaig C.
    Pediatr Dermatol; 2006 Mar 01; 23(6):574-9. PubMed ID: 17156002
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.